Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase 2 Study of Neoadjuvant Enzalutamide and Paclitaxel for Luminal Androgen Receptor-Enriched TNBC: Trial Results and Insights into “Arness”

Bora Lim,Sahil Seth,Clinton Yam,Lei Huo,Takeo Fujii,Jangsoon Lee,Roland Bassett, Sara Nasser, Lisa Ravenberg,Jason White,Alyson Clayborn, Gil Guerra,Jennifer K. Litton,Senthil Damodaran,Rachel Layman,Vicente Valero,Debasish Tripathy,Michael Lewis,Lacey E. Dobrolecki,Jonathan Lei,Rosalind Candelaria,Banu Arun,Gaiane Rauch,Li Zhao,Jianhua Zhang,Qingqing Ding,W. Fraser Symmans,Jeffrey T. Chang,Alastair M. Thompson,Stacy L. Moulder,Naoto T. Ueno

Cell Reports Medicine（2024）

Cited 0|Views7
Key words
triple-negative breast cancer,androgen receptor,enzalutamide,ARness,biomarker of response,LAR subtype,TNBC,neoadjuvant systemic therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined